Submission of Matters to a Vote of Security

A special meeting of stockholders of Aytu BioScience, Inc. was held on July 26, 2017.

At the meeting, our stockholders took the following actions:

1.

Approved an amendment to our Certificate of Incorporation to effect a reverse stock split at a ratio of any whole number up to 1-for-20, as determined by our board of directors, at any time before November 14, 2018 (or such other date that is one year after the date of our 2018 annual meeting of stockholders), if and as determined by our board of directors. The vote was 9,707,984 for, 1,580,963 against, 97,749 shares abstaining and no broker non-votes.

2.

Approved an amendment to our 2015 Stock Option and Incentive Plan to (i) increase the number of authorized shares of common stock reserved for issuance thereunder from 2,000,000 to 3,000,000, (ii) increase the number of shares that may be issued as incentive stock options from 2,000,000 to 3,000,000, (iii) increase the maximum number of shares of common stock (A) underlying stock options or stock appreciation rights that may be granted to any one individual during any calendar year period, and (B) granted to any one individual that is intended to qualify as performance-based compensation under Section 162(m) of the Internal Revenue Code of 1986, as amended, for any performance cycle from 1,000,000 to 2,000,000, and (iv) in the event that we effect a reverse stock split prior to November 14, 2018 (or such other date that is one year after the date of our 2018 annual meeting of stockholders), immediately after the effective time of such reverse stock split, (A) the maximum number of shares reserved under the Plan will be automatically increased to 3,000,000, (B) the maximum number of shares that may be issued pursuant to any type of award will be automatically increased to 3,000,000, (C) the number of shares that may be granted to any one individual during any one calendar year period as stock options or stock appreciation rights will be automatically increased to 2,000,000, and (D) the number of shares that may be issued in the form of incentive stock options will be automatically increased to 3,000,000. The vote was 6,377,095 for, 630,660 against, 26,123 shares abstaining and 4,352,818 broker non-votes.

Item 9.01

Financial Statements and Exhibits.

(d)

Exhibits

Exhibit No.

Description

10.1

2015 Stock Option and Incentive Plan, as amended on July 26, 2017.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: July 27, 2017

AYTU BIOSCIENCE, INC.

/s/ Gregory A. Gould

Name:Gregory A. Gould

Title:Chief Financial Officer

makes a similar move, sign up!

Other recent filings from the company include the following:

General form for registration of securities under the Securities Act of 1933 - Sept. 22, 2017
General form for registration of securities under the Securities Act of 1933 - Sept. 5, 2017
Rosewind: Aytu Bioscience Provides Fiscal Fourth Quarter And Year-End 2017 Business Update - Aug. 31, 2017
Rosewind CORP Just Filed Its Annual Report: Note 14 – Subsequ... - Aug. 31, 2017
Rosewind: Aytu Bioscience Provides Fiscal Fourth Quarter And Year-End 2017 Business Update - Aug. 31, 2017

Auto Refresh

Feedback